Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2020-11-27 | Ian B. Walters, M.D. has been a director of the Company since November 25, 2020. ... Dr. Walters is currently CEO and Director of Portage Biotech, a publicly traded clinical stage biopharmaceutical company developing an innovative portfolio of immuno-oncology assets. ... Dr. Walters has been the lead author or contributor to approximately 60 journal publications. |
| 2022-03-01 | Ian B. Walters, M.D. has been a director of the Company since November 25, 2020. Mr. Walters is currently chair of the Company’s Compensation Committee and a member of the Company’s Nominating/ Governance Committee and Audit Committee. |
| 2022-12-21 | Ian B. Walters, M.D. has been a director of the Company since November 2020. Mr. Walters is currently chair of the Company’s Compensation Committee and a member of the Company’s Audit Committee and Nominating & Governance Committee. ... The following table sets forth the information concerning compensation earned during our fiscal year ended July 31, 2022 by all non-employee Directors: ... Ian B. Walters, M.D. $75,000 Fees Earned or Paid in Cash, $200,000 Restricted Stock Unit Awards, Total $275,000. |
Data sourced from SEC filings. Last updated: 2025-08-30